Very Low-Dose Dasatinib Is a Safe and Effective Therapy for Elderly Patients with Newly-Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results from the Davlec Study, a Single-Arm, Multicenter, Phase 2 TrialTakashi Kumagai,Kazunori Murai, Hiroshi Ureshino,Hideo Tanaka,Kaichi Nishiwaki,Satoshi Wakita,Koiti Inokuchi,Toshihiro Fukushima,Chikashi Yoshida,Masayuki Mita,Nobuhiko Uoshima,Toru Kiguchi,Jun Aoki,Satoshi Kimura,Kaori Karimata,Kensuke Usuki,Joji Shimono,Yoshiaki Chinen,Junya Kuroda,Yasufumi Matsuda,Kensuke Nakao,Takaaki Ono,Katsumichi Fujimaki,Hirohiko Shibayama,Chisaki Mizumoto,Tomoharu Takeoka,Katsuhiro Io,Takeshi Kondo,Masatomo Miura,Yosuke Minami,Takayuki Ikezoe,Jun Imagawa,Ayako Takamori,Atsushi Kawaguchi,Junichi Sakamoto, Shinya KimuraBLOOD（2021）引用 2|浏览26暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
